+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 99Years
All Genders
ID03712722

Observational Study of Fecal Microbiota Transplantation for Clostridium Difficile Infection Treatment at Aarhus University Hospital

Led by University of Aarhus · Updated on 2026-10-16

2000

Participants Needed

1

Research Sites

104 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying fecal microbiota transplantation FMT as a treatment for Clostridioides difficile infection CDI, focusing on patients with recurrent, first-time, refractory, or severe infections. This observational cohort study is conducted within a quality improvement framework at Aarhus University Hospital and associated hospitals. Participants receive FMT through various delivery methods, including colonoscopy, nasojejunal tube, glycerol-based capsules, or freeze-dried encapsulated donor feces. Treatments are integrated into the hospital care system and monitored as part of the project. During the study, participants are assessed, treated, and monitored at Aarhus University Hospital and related centers. Researchers measure the resolution of Clostridium difficile-associated disease at 8 weeks as the primary outcome, along with clinical effects and negative infection tests at the same timepoint. The study spans several years, from 2018 to 2031, allowing long-term observation and monitoring.

CONDITIONS

Brief Title

Fecal Microbiota Transplantation (FMT) for Clostridium Difficile

Research Team

C

Christian L Hvas, MD PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here